(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-a-a-diphenyl-3-pyrrolidineacetamide Hydrobromide Darifenacin hydrobromide darifenacin HBr 133099-07-7 UK 88525-04 hydrobromide CR02EYQ8GV UK-88525-04 (HYDROBROMIDE) DTXSID9046780 Uk-88525-04 (hbr) DTXCID7026780 CHEBI:31455 (S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide (S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HYDROBROMIDE (S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide Darifenacin 15 mg Darifenacin 7.5 mg RefChem:57151 Enablex Emselex MFCD08141803 Darifenacin hydrobromide [USAN] Darifenacin (hydrobromide) (S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide hydrobromide 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide 3-PYRROLIDINEACETAMIDE, 1-[2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL]-ALPHA,ALPHA-DIPHENYL-, HYDROBROMIDE (1:1), (3S)- Darilong 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide CAS-133099-07-7 NCGC00168775-01 UNII-CR02EYQ8GV C28H31BrN2O2 Emselex; (S)-2-[1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide Hydrobromide 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide Enablex (TN) Darifenacinhydrobromide 133099-07-7 (HBr) SCHEMBL453486 Diphenyl-acetamide hydrobromide orb1308291 CHEMBL1200935 SCHEMBL29519864 HY-A0012R GLXC-05124 HY-A0012 Tox21_112636 Darifenacin hydrobromide (JAN/USAN) DARIFENACIN HYDROBROMIDE [MI] EBC-11257 s3144 DARIFENACIN HYDROBROMIDE [JAN] AKOS015969311 Darifenacin (hydrobromide) (Standard) Tox21_112636_1 AC-1894 CCG-220969 CS-0380 FD10806 DARIFENACIN HYDROBROMIDE [MART.] DARIFENACIN HYDROBROMIDE [USP-RS] DARIFENACIN HYDROBROMIDE [WHO-DD] NCGC00263922-02 3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (3S)- 3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (S)- AS-35087 SY103034 DARIFENACIN HYDROBROMIDE [EMA EPAR] Darifenacin hydrobromide, >=98% (HPLC) SW219426-1 DARIFENACIN HYDROBROMIDE [ORANGE BOOK] UK-88525-04 D01699 EN300-123031 F794024 Q27114313 Z1546616192 (S)-2-[1-[2-(2,3-Dihydrobenzfuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide HBr Darifenacin hydrobromide, United States Pharmacopeia (USP) Reference Standard (1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide (S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HBR 2-[(3S)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide;hydrobromide 2-{(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide--hydrogen bromide (1/1) 3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHBR, (3S)- 3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHYDROBROMIDE, (3S)- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-|A,|A-diphenyl-, hydrobromide (1:1), (3S)-
Mostrar todos os 85 sinônimos